What Does Optical Coherence Tomography Offer for Evaluating Physical Disability in Patients with Multiple Sclerosis?

Visual dysfunction is one of the most common clinical manifestations of multiple sclerosis (MS). For example, optic neuritis is the onset symptom in 20% of patients with MS. Visual pathway impairment presents in most patients with MS, including patients who have not experienced optic neuritis. During the last decade, many clinical trials of MS have included visual outcomes. One tool used in these studies, optical coherence tomography, is a non-contact, noninvasive, high-resolution optical imaging technology that helps segmentation and measurement of specific retinal layers using computerized algorithms. Optical coherence tomography is used in various stages of MS from diagnosis to treatment of the disease. In this review, we summarize the use of optical coherence tomography in MS and study its usefulness for evaluating the physical disabilities of MS patients.

[1]  A. Carotenuto,et al.  Optical coherence tomography angiography retinal vascular network assessment in multiple sclerosis , 2018, Multiple sclerosis.

[2]  Sara Llufriu,et al.  Predictors of vision impairment in Multiple Sclerosis , 2018, PloS one.

[3]  J. Frederiksen,et al.  Optical coherence tomography in multiple sclerosis , 2018, Eye.

[4]  A C S Tan,et al.  An overview of the clinical applications of optical coherence tomography angiography , 2018, Eye.

[5]  Leopold Schmetterer,et al.  Optical coherence tomography angiography: a review of current and future clinical applications , 2018, Graefe's Archive for Clinical and Experimental Ophthalmology.

[6]  B. Uitdehaag,et al.  Diagnostic accuracy of optical coherence tomography inter‐eye percentage difference for optic neuritis in multiple sclerosis , 2017, European journal of neurology.

[7]  Kumar Sambhav,et al.  The application of optical coherence tomography angiography in retinal diseases. , 2017, Survey of ophthalmology.

[8]  P. Nucci,et al.  Faculty Opinions recommendation of Disease-modifying therapies modulate retinal atrophy in multiple sclerosis: A retrospective study. , 2017 .

[9]  M. Mühlau,et al.  Association of Retinal Architecture, Intrathecal Immunity, and Clinical Course in Multiple Sclerosis , 2017, JAMA neurology.

[10]  V. Polo,et al.  Retinal and Optic Nerve Degeneration in Patients with Multiple Sclerosis Followed up for 5 Years. , 2017, Ophthalmology.

[11]  S. Khoury,et al.  Retinal measures correlate with cognitive and physical disability in early multiple sclerosis , 2016, Journal of Neurology.

[12]  Alexander Klistorner,et al.  Retinal thickness measured with optical coherence tomography and risk of disability worsening in multiple sclerosis: a cohort study , 2016, The Lancet Neurology.

[13]  Friedemann Paul,et al.  Retinal pathology in Susac syndrome detected by spectral-domain optical coherence tomography , 2015, Neurology.

[14]  P. Villoslada,et al.  Color vision impairment in multiple sclerosis points to retinal ganglion cell damage , 2015, Journal of Neurology.

[15]  Snehashis Roy,et al.  Optical coherence tomography reflects brain atrophy in multiple sclerosis: A four‐year study , 2015, Annals of neurology.

[16]  Ilana Katz Sand,et al.  Classification, diagnosis, and differential diagnosis of multiple sclerosis , 2015 .

[17]  F. Costello.  Optical coherence tomography technologies: which machine do you want to own? , 2014, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.

[18]  Joachim Hornegger,et al.  Optical coherence tomography angiography of optic nerve head and parafovea in multiple sclerosis , 2014, British Journal of Ophthalmology.

[19]  Ariel Miller,et al.  Revised diagnostic criteria of multiple sclerosis. , 2014, Autoimmunity reviews.

[20]  C. Cadarso-Suárez,et al.  Retinal Nerve Fiber Layer Thickness, Brain Atrophy, and Disability in Multiple Sclerosis Patients , 2014, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.

[21]  D. Karussis,et al.  The diagnosis of multiple sclerosis and the various related demyelinating syndromes: a critical review. , 2014, Journal of autoimmunity.

[22]  Axel Petzold,et al.  Optical Coherence Tomography Reveals Distinct Patterns of Retinal Damage in Neuromyelitis Optica and Multiple Sclerosis , 2013, PloS one.

[23]  J. Duker,et al.  Optical coherence tomography – current and future applications , 2013, Current Opinion in Ophthalmology.

[24]  S. A. Meyer,et al.  Active MS is associated with accelerated retinal ganglion cell/inner plexiform layer thinning , 2013, Neurology.

[25]  F. Paul,et al.  Retinal Damage in Multiple Sclerosis Disease Subtypes Measured by High-Resolution Optical Coherence Tomography , 2012, Multiple sclerosis international.

[26]  E. Ringelstein,et al.  Patterns of Retinal Damage Facilitate Differential Diagnosis between Susac Syndrome and MS , 2012, PloS one.

[27]  Hiroshi Ishikawa,et al.  Ganglion cell loss in relation to visual disability in multiple sclerosis. , 2012, Ophthalmology.

[28]  A. Green,et al.  Microcystic macular oedema in multiple sclerosis is associated with disease severity. , 2012, Brain : a journal of neurology.

[29]  S. A. Meyer,et al.  Visual dysfunction in multiple sclerosis correlates better with optical coherence tomography derived estimates of macular ganglion cell layer thickness than peripapillary retinal nerve fiber layer thickness , 2011, Multiple sclerosis.

[30]  Axel Petzold,et al.  Optical coherence tomography in multiple sclerosis: a systematic review and meta-analysis , 2010, The Lancet Neurology.

[31]  Ute Wolf-Schnurrbusch,et al.  Spectral-Domain Optical Coherence Tomography Use in Macular Diseases: A Review , 2010, Ophthalmologica.

[32]  M. Freedman,et al.  Differences in retinal nerve fiber layer atrophy between multiple sclerosis subtypes , 2009, Journal of the Neurological Sciences.

[33]  W. Freeman,et al.  Imaging vitreomacular interface abnormalities in the coronal plane by simultaneous combined scanning laser and optical coherence tomography , 2008, British Journal of Ophthalmology.

[34]  J. Sepulcre,et al.  Retinal nerve fiber layer atrophy is associated with physical and cognitive disability in multiple sclerosis , 2008, Multiple sclerosis.

[35]  D Thomas,et al.  Optical coherence tomography—a review of the principles and contemporary uses in retinal investigation , 2004, Eye.

[36]  P. Calabresi,et al.  Optical Coherence Tomography (OCT): Imaging the Visual Pathway as a Model for Neurodegeneration , 2010, Neurotherapeutics.

[37]  G. Ripandelli,et al.  Optical coherence tomography. , 1998, Seminars in ophthalmology.